# 21 CFR 312.82 Early consultation.

21 CFR 312.82 Early consultation., “Early consultation”, is a CFR section of [21 CFR Part 312, Subpart E—Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses](https://ontology.bommaritollc.com/id/01a0f094-b5ed-703e-98ee-c9a03550ea01); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64f55ace1b2>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter D—DRUGS FOR HUMAN USE](https://ontology.bommaritollc.com/id/01a0f094-b5e4-722f-99b0-5c1856aef2a9) › [21 CFR Part 312—Investigational new drug application](https://ontology.bommaritollc.com/id/01a0f094-b84c-75c3-a0c0-d388d85f1044) › [21 CFR Part 312, Subpart E—Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses](https://ontology.bommaritollc.com/id/01a0f094-b5ed-703e-98ee-c9a03550ea01)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 312.82](https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b65b5046c3c7)
- `eli:cites`: [21 CFR 312.47 Meetings.](https://ontology.bommaritollc.com/id/01a0f094-c49c-72a8-a729-6c385a1bafd9)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64ed668110f)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e317-701b-b1cc-06e9077454fc)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c4e3-72a2-89bc-066d6ba09049)
  - [evidence from https://www.govinfo.gov/link/cfr/21/312?sectionnum=82&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-67b6-7735-93ab-afd1b542d43d)
- `schema:isPartOf`: [21 CFR Part 312, Subpart E—Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses](https://ontology.bommaritollc.com/id/01a0f094-b5ed-703e-98ee-c9a03550ea01)
- `schema:legislationIdentifier`: 21 CFR 312.82
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Early consultation
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/312?sectionnum=82&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/312?sectionnum=82&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 312.82 Early consultation.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/312?sectionnum=82&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (2; `eli:cites`):
  - [21 CFR 312.84 Risk-benefit analysis in review of marketing applications for drugs to treat life-threatening and severely-debilitating illnesses.](https://ontology.bommaritollc.com/id/01a0f094-c4ad-70e9-8fec-e2b1899763eb)
  - [21 U.S.C. 355c Research into pediatric uses for drugs and biological products](https://ontology.bommaritollc.com/id/01a0f06c-ccdc-7622-b131-6752c5c696e4)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64f55ace1b2.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64f55ace1b2.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64f55ace1b2.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64f55ace1b2)
Cite as: 21 CFR 312.82 Early consultation.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c4ac-751a-b3e2-b64f55ace1b2
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
